MedPath

Ocellaris Pharma, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Phase 1
Recruiting
Conditions
Cancer
Squamous Cell Carcinoma
Merkel Cell Carcinoma
Neoplasms
Triple Negative Breast Cancer
Ovarian Cancer
Bladder Cancer
Gastric Cancer
Urothelial Carcinoma
Metastatic Cancer
Interventions
First Posted Date
2020-02-07
Last Posted Date
2025-07-20
Lead Sponsor
Ocellaris Pharma, Inc.
Target Recruit Count
116
Registration Number
NCT04260802
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

🇨🇦

Ottawa Hospital Cancer Centre (OHRI), Ottawa, Ontario, Canada

🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.